Gliclazide
Gliclazide (SE1702) is a sulfonylurea insulin secretagogue that promotes insulin secretion from pancreatic beta-cells. It is widely used in diabetes research, including in vitro studies of insulin release mechanisms and in vivo models of type 2 diabetes.
Product Specifications
CAS Number
21187-98-4
Product Name Alternative
Gliclazide, KcsA, Inhibitor, inhibit, SE1702, SE-1702, SE 1702, PotassiumChannel, Potassium Channel, S 1702, S1702, S-1702
Field of Research
Pharmacology & Drug Discovery
Purity
98.08% (May vary between batches)
Solubility
H2O:< 1 mg/mL (insoluble or slightly soluble) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (6.18 mM) ; Ethanol:< 1 mg/mL (insoluble or slightly soluble) ; DMSO:45 mg/mL (139.14 mM)
Smiles
CC1=CC=C (C=C1) S (=O) (=O) NC (=O) NN1CC2CCCC2C1
Molecular Formula
C15H21N3O3S
Molecular Weight
323.41
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
036798-PE 200 µL
HSPA12B, NT (HSPA12B, C20orf60, Heat shock 70kD protein 12B) (PE) discontinued
Sign In for Pricing
View Details 
MBS6436985-01 0.1 mL
SEMG1 (Semenogelin I, SGI, SEMG, CT103, dJ172H20.2) (MaxLight 490)
Sign In for Pricing
View Details MBS6436985-02 5x 0.1 mL
SEMG1 (Semenogelin I, SGI, SEMG, CT103, dJ172H20.2) (MaxLight 490)
Sign In for Pricing
View Details